The most common approach we see is a structured maintenance plan
Guerrero-Bosagna, C., Settles, M., Lucker, B
Tesamorelin gained FDA approval in 2010 for reducing visceral adipose tissue, with clinical trials demonstrating 1518% reductions in visceral fat after 26 weeks at 2mg daily dosing
PMID: 29495598 Barcelos RP, Lima FD, Carvalho NR, Bresciani G, Royes LF
Supports Brain Repair and Function: Substance abuse can damage brain cells and impair cognitive function
Wound Healing and Tissue Remodeling Originally studied for wound healing, GHK-Cu enhances: Angiogenesis (formation of new blood vessels) Fibroblast migration and activity Tissue remodeling These effects translate into faster recovery and improved skin quality, optimizing results after procedures such as microneedling or laser treatments